Analyst Profile

Followed by 123 followers
.
Marc Goodman

Marc Goodman

SVB Securities
Wall Street Analyst
#6,953 out of 8,141 Wall Street Analysts
#20,848 out of 24,284 experts

Success Rate

41%
173 out of 417 transactions made a profit

Average Return

-2.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Marc Goodman's trades since 2010 and holding each position for 1 Year would result in 41.49% of your transactions generating a profit, with an average return of -2.1% per rating.

Stock Rating Distribution

725Ratings
73.66% Buy
24.41% Hold
1.93% Sell
Distribution of Marc Goodman's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
Amylyx Pharmaceuticals, Inc.
(AMLX)
Rating:Buy
Date:May 12, 2022 - Today
Return:+402.00%
The most profitable rating made by Marc Goodman

Marc Goodman's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
WCRX
Warner Chilcott
Apr 14, 2010
Buy
Reiterated
1Ratings
0.00%
~FRX
Forest Labs
May 19, 2014
Hold
Reiterated
3Ratings
0.00%
AUXL
Auxilium
Sep 19, 2014
Hold
Downgraded
1Ratings
0.00%
CBST
Cubist Pharma
Dec 16, 2014
Hold
Reiterated
3Ratings
0.00%
SLXP
Salix
Feb 24, 2015
Hold
Downgraded
6Ratings
100%
+35.63%
Bausch Health Companies
Mar 21, 2016
Buy
Assigned
24Ratings
44%
-32.66%
Ironwood Pharma
Jun 14, 2016
Sell
Reiterated
$8.00
(-33.88% Downside)
3Ratings
0%
-54.97%
MNTA
Momenta Pharma
Jun 14, 2016
Sell
Reiterated
5Ratings
67%
+10.17%
Assertio Therapeutics
Jun 14, 2016
Buy
Reiterated
$20.00
(547.25% Upside)
1Ratings
0%
-50.60%
Endo International
Aug 08, 2016
Buy
Reiterated
$30.00
(32227.59% Upside)
5Ratings
50%
-7.63%
List of latest recommendations made by Marc Goodman. Click to expand and see Marc Goodman's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >